- Home
- WMK vs BCRX Comparison
WMK vs BCRX Comparison
Compare WMK & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WMK
- BCRX
- Stock Information
- Founded
- WMK 1912
- BCRX 1986
- Country
- WMK United States
- BCRX United States
- Employees
- WMK N/A
- BCRX N/A
- Industry
- WMK Food Chains
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WMK Consumer Staples
- BCRX Health Care
- Exchange
- WMK Nasdaq
- BCRX Nasdaq
- Market Cap
- WMK 1.7B
- BCRX 1.7B
- IPO Year
- WMK N/A
- BCRX 1994
- Fundamental
- Price
- WMK $70.70
- BCRX $7.49
- Analyst Decision
- WMK
- BCRX Strong Buy
- Analyst Count
- WMK 0
- BCRX 5
- Target Price
- WMK N/A
- BCRX $15.60
- AVG Volume (30 Days)
- WMK 82.6K
- BCRX 2.4M
- Earning Date
- WMK 11-05-2024
- BCRX 11-04-2024
- Dividend Yield
- WMK 1.91%
- BCRX N/A
- EPS Growth
- WMK N/A
- BCRX N/A
- EPS
- WMK 3.56
- BCRX N/A
- Revenue
- WMK $4,759,577,000.00
- BCRX $412,579,000.00
- Revenue This Year
- WMK N/A
- BCRX $37.24
- Revenue Next Year
- WMK N/A
- BCRX $19.30
- P/E Ratio
- WMK $19.69
- BCRX N/A
- Revenue Growth
- WMK N/A
- BCRX 29.92
- 52 Week Low
- WMK $58.87
- BCRX $4.03
- 52 Week High
- WMK $76.62
- BCRX $8.88
- Technical
- Relative Strength Index (RSI)
- WMK 54.27
- BCRX 48.27
- Support Level
- WMK $68.60
- BCRX $6.92
- Resistance Level
- WMK $74.80
- BCRX $8.25
- Average True Range (ATR)
- WMK 2.36
- BCRX 0.46
- MACD
- WMK -0.16
- BCRX -0.05
- Stochastic Oscillator
- WMK 54.08
- BCRX 45.71
About WMK Weis Markets Inc.
Weis Markets Inc is a U.S.-based company that is principally engaged in retailing food products in Pennsylvania and surrounding states. The company's products consist of center-store goods, fresh goods, pharmacy services, fuel, and others. The center-store goods include groceries, dairy products, frozen foods, alcoholic beverages, and general merchandise items. The fresh goods include meats, seafood, floral, prepared foods, and bakery products. The center-store goods and fresh goods jointly account for the majority of the company's total revenue.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.